ICMH
TLSIW icon

Integrity Capital Management (HK)’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Integrity Capital Management (HK)’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-56,623
Closed -$30K – 215
2021
Q4 		$30K Buy
+56,623
New +$52K 0.1% 231

Other funds holding TLSIW

Mangrove Partners
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
Radcliffe Capital Management
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
Angelo Gordon & Co
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
Magnetar Financial
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.6B AUM 113.36% 1-Year Est. Return
Polar Asset Management Partners
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Islet Management
Islet Management New York $49.1M AUM 17.59% 1-Year Est. Return
Spring Creek Capital
Spring Creek Capital Wichita, Kansas $2.53B AUM 19.59% 1-Year Est. Return
Vestcor Inc
Vestcor Inc Fredericton, New Brunswick, Canada $4.05B AUM 34.56% 1-Year Est. Return
Kepos Capital
Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return

Integrity Capital Management (HK)'s TLSIW Position: Q1 2022 in Review

Integrity Capital Management (HK) sold out of TriSalus Life Sciences Warrant (TLSIW) in Q1 2022, closing a stake of 56,623 shares — an estimated $30K sold.

Integrity Capital Management (HK) first reported a position in TLSIW in Q4 2021 and held it in 1 quarter. The position peaked at $30K in Q4 2021. 26 funds tracked by Wall St. Rank hold TLSIW as of Q1 2022.

  • Integrity Capital Management (HK) reported no remaining TriSalus Life Sciences Warrant position as of Q1 2022 after selling out during the quarter.
  • Integrity Capital Management (HK) sold 56,623 TriSalus Life Sciences Warrant shares in Q1 2022, an estimated $30K.
  • Integrity Capital Management (HK) first reported a position in TriSalus Life Sciences Warrant in Q4 2021 and held it in 1 quarter.
  • Integrity Capital Management (HK)'s TriSalus Life Sciences Warrant position peaked at $30K in Q4 2021.
  • 26 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q1 2022.

Based on Integrity Capital Management (HK)'s 13F filing for Q1 2022, filed 26 Apr 2022.